ACT-GLOBAL Adaptive Platform Trial for Stroke
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Demchuk, MD
University of Calgary
Principal Investigator - Bijoy Menon, MD
University of Calgary
Principal Investigator - Craig Anderson, MD, PhD
The George Institute
Principal Investigator - Michael D Hill, MD
University of Calgary
Principal Investigator - Xiaoying Chen, PhD
The George Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the George Institute for Global Health
Sydney, New South Wales, Australia
Recruiting
- University of Calgary
Calgary, Alberta, Canada
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2024
- Primary completion
- 30 Sept 2034
- Completion
- 30 Sept 2034
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 20,000
- Registry id
- NCT06352632
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.